Table 1 Patient characteristics categorized by the number of DFPP sessions
0 (n = 216) | 1 (n = 34) | 2 (n = 31) | \(\ge\) 3 (n = 13) | P | |
|---|---|---|---|---|---|
Age (years) | 49 ± 14 | 51 ± 15 | 50 ± 14 | 56 ± 12 | 0.3436 |
Sex (M/F) | 159/57 | 22/12 | 19/12 | 5/8 | 0.0291 |
Body mass index (kg/m2) | 22.7 ± 4.1 | 22.4 ± 3.1 | 22.5 ± 5.0 | 21.9 ± 7.8 | 0.9238 |
Primary cause of ESRD | 0.0194 | ||||
Diabetic nephropathy | 59 (27.3%) | 7 (20.6%) | 8 (25.8%) | 2 (15.4%) | |
IgA nephropathy | 43 (19.9%) | 5 (14.7%) | 6 (19.4%) | 1 (7.7%) | |
Nephrosclerosis | 11 (5.1%) | 8 (23.5%) | 1 (3.2%) | 2 (15.4%) | |
ADPKD | 10 (4.6%) | 3 (8.8%) | 4 (12.9%) | 0 (0%) | |
Others (including unknown primary disease) | 93 (43.1%) | 11 (32.4%) | 12 (38.7%) | 8 (61.5%) | |
ABO-ILKT/ABO-CLKT | 17/199 | 28/6 | 21/10 | 7/6 | < 0.001 |
DSA (+) | 10 (4.6%) | 5 (14.7%) | 8 (25.8%) | 8 (61.5%) | < 0.001 |
Continuation of antiplatelet agents at surgery | 26 (12.0%) | 4 (11.7%) | 4 (12.9%) | 2 (15.4%) | 0.9855 |
Donor age (years) | 60 ± 10 | 59 ± 9 | 59 ± 11 | 64 ± 9 | 0.5131 |
Donor sex (M/F) | 55/161 | 12/22 | 11/20 | 7/6 | 0.0894 |